Atossa Therapeutics Inc. (ATOS)

NASDAQ: ATOS · Real-Time Price · USD

0.85

-0.05 (-5.33%)

At close: May 01, 2025, 3:59 PM

0.84

-0.80%

Pre-market: May 02, 2025, 08:00 AM EDT

Atossa Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-25.5M	-30.09M	-26.96M	-20.61M	-17.83M	-17.24M	-11.4M	-8.12M	-6.37M
Depreciation & Amortization	17K	23K	8K	23K	46.52K	52.79K	44.2K	128.99K	303.48K
Stock-Based Compensation	2.29M	4.62M	6.79K	5.27K	3.02M	8.84M	2.46M	786.55K	876.19K
Other Working Capital	575K	391K	-1.85M	-1.28M	-1.41M	-731.14K	-82.83K	-420.47K	-507.55K
Other Non-Cash Items	1.72M	2.99M	3K	5.62M	938.79K	5.81K	2.69M	192.82K	1.6M
Deferred Income Tax	n/a	n/a	n/a	-5.62M	2.36M	n/a	n/a	760.16K	-712.86K
Change in Working Capital	448K	1.52M	-599K	-1.16M	-111.35K	-791.3K	-64.41K	-339.89K	-1.07M
Operating Cash Flow	-21.03M	-20.94M	-20.76M	-16.47M	-11.57M	-9.13M	-8.96M	-6.59M	-5.37M
Capital Expenditures	-19K	-14	-27K	-9K	-9.37K	-7.63K	-110.91K	n/a	-9.21K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-4.7M	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-4.7K	-9K	-9.37K	-7.63K	-110.91K	n/a	-9.21K
Investing Cash Flow	-19K	-14	-4.73M	-9K	-9.37K	-7.63K	-110.91K	n/a	-9.21K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	-1.48K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	3.67M	n/a	n/a	43.64M	-13.82K	11.34M	n/a	749.23K	n/a
Financial Cash Flow	3.67M	-1.48K	n/a	113.3M	38.55M	11.34M	12.29M	10.78M	4.7M
Net Cash Flow	-17.38M	-22.43K	-25.49M	96.82M	26.97M	2.2M	3.22M	4.19M	-687.93K
Free Cash Flow	-21.05M	-20.95K	-20.79M	-16.48M	-11.58M	-9.14M	-9.07M	-6.59M	-5.38M